Effective bronchodilator treatment by a simple spacer device for wheezy premature infants.

B Yuksel, A Greenough, I Maconochie

Department of Child Health, King's College Hospital, London.

Ten preterm infants with recurrent respiratory symptoms (median gestational age 30 weeks) were entered into a non-randomised placebo controlled trial of bronchodilator treatment at 12.5 months of age. The infants had coughed or wheezed, or both, on at least four days a week for the past month. The infants received either placebo or 500 micrograms terbutaline from an inhaler using a coffee cup as a spacer device. Each treatment was maintained for two weeks, first placebo then active drug. The symptom score was reduced by 65% during the active treatment period compared with the placebo period and this was associated with a 32% improvement in lung function, reflected in an increase in functional residual capacity. We conclude that inhaled bronchodilator treatment given with a simple spacer device is useful for preterm infants with recurrent respiratory symptoms in the first two years of life.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Effective bronchodilator treatment by a simple spacer device for wheezy premature infants.

N Wilson
Arch. Dis. Child. 1991 66: 171. [PDF]

This article has been cited by other articles:

• (2003). Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood. Am. J. Respir. Crit. Care Med. 168: 356-396 [Full Text]  
• Hickey, R. W., Gochman, R. F., Chande, V., Davis, H. W. (1994). Albuterol Administered by Metered-Dose Inhaler and Spacer to Young Children With Wheezing-Reply. Arch Pediatr Adolesc Med 148: 1353-1354 [Abstract]  
• Hickey, R. W., Gochman, R. F., Chande, V., Davis, H. W. (1994). Albuterol Delivered via Metered-Dose Inhaler With Spacer for Outpatient Treatment of Young Children With Wheezing. Arch Pediatr Adolesc Med 148: 189-194 [Abstract]